TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis

• Published in: Cell death and differentiation 2022-07, Vol.29 (7), p.1364-1378
• Main Authors: Yoon, Dong Suk, Lee, Kyoung-Mi, Choi, Yoorim, Ko, Eun Ae, Lee, Na-Hyun, Cho, Sehee, Park, Kwang Hwan, Lee, Jung-Hwan, Kim, Hae-Won, Lee, Jin Woo
• Format: Article
• Language: English
• Subjects: 3' Untranslated regions; 38; 38/109; 38/77; 38/89; 42/44; 631/80; 64/60; 692/699/249; 82/80; Aging; Animal models; Animals; Apoptosis; Arthritis; Biochemistry; Biomedical and Life Sciences; Cartilage (articular); Cartilage diseases; Cell Biology; Cell Cycle Analysis; Cell self-renewal; Cellular Senescence; Chondrocytes; Down-Regulation; Gene therapy; Humans; Hydrogen peroxide; Hydrogen Peroxide - metabolism; IL-1β; Inflammation; Interleukin-1beta - metabolism; Life Sciences; Lipopolysaccharides; Mesenchyme; Mice; mRNA; NF-kappa B - metabolism; NF-κB protein; Osteoarthritis; Osteoarthritis - genetics; Osteoarthritis - pathology; Osteoarthritis - therapy; Phenotypes; Post-transcription; RNA-binding protein; RNA-Binding Proteins - genetics; RNA-Binding Proteins - metabolism; Senescence; Stem cell transplantation; Stem Cells; Therapeutic targets; TLR4 protein; Toll-Like Receptor 4 - genetics; Toll-Like Receptor 4 - metabolism; Toll-like receptors
• ISSN: 1350-9047; 1476-5403
• DOI: 10.1038/s41418-021-00925-6

Dysfunction of mRNA or RNA-binding proteins (RBPs) causes cellular aging and age-related degenerative diseases; however, information regarding the mechanism through which RBP-mediated posttranscriptional regulation affects cellular aging and related disease processes is limited. In this study, PUM1 was found to be associated with the self-renewal capacity and aging process of human mesenchymal stem cells (MSC). PUM1 interacted with the 3’-untranslated region of Toll-like receptor 4 (TLR4) to suppress TLR4 mRNA translation and regulate the activity of nuclear factor-κB (NF-κB), a master regulator of the aging process in MSCs. PUM1 overexpression protected MSCs against H 2 O 2 -induced cellular senescence by suppressing TLR4-mediated NF-κB activity. TLR4-mediated NF-κB activation is a key regulator in osteoarthritis (OA) pathogenesis. PUM1 overexpression enhanced the chondrogenic potential of MSCs even under the influence of inflammation-inducing factors, such as lipopolysaccharide (LPS) or interleukin-1β (IL-1β), whereas the chondrogenic potential was reduced following the PUM1 knockdown-mediated TLR4 activation. PUM1 levels decreased under inflammatory conditions in vitro and during OA progression in human and mouse disease models. PUM1 knockdown in human chondrocytes promoted chondrogenic phenotype loss, whereas PUM1 overexpression protected the cells from inflammation-mediated disruption of the chondrogenic phenotype. Gene therapy using a lentiviral vector encoding mouse PUM1 showed promise in preserving articular cartilage integrity in OA mouse models. In conclusion, PUM1 is a novel suppressor of MSC aging, and the PUM1-TLR4 regulatory axis represents a potential therapeutic target for OA.